end-stage hip disease
Conditions
Interventions
hip arthroplasty group:total hip arthroplasty and hip revisoin arthroplasty
Sponsors
Department of Orthopedics, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: patients undergoing total knee arthroplasty and hip revision arthroplasty using S-ROM stem for the treatment of end-stage hip disease will be recruited for our trial
Exclusion criteria
Exclusion criteria: non-hip arthroplasty patients and patients undergoing hip arthroplasty using non-S-ROM stem
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Harris score;joint range of motion;postoperative complications;implant survival rate;radiographic results; | — |
Countries
China
Contacts
Public ContactZeng Yi
West China Hospital, Sichuan University
Outcome results
None listed